Skip to content

The multicenter randomized controlled study for Qihuang yishen granule improve proteinuria of diabetic kidney disease

The multicenter randomized controlled study for Qihuang yishen granule improve proteinuria of diabetic kidney disease

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022275
Enrollment
Unknown
Registered
2019-04-02
Start date
2019-04-10
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease

Interventions

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? meet the Western diagnostic criteria of Diabetic kidney disease and diagnostic criteria for TCM syndromes; ? age 30 to 75 years (including 30 and 75 years); ? 24h urine protein quantification between 0.5 ~ 3.5g, eGFR30 ~ 90ml/min; ? after antihypertensive treatment, the blood pressure is controlled at =140/90mmHg; ? the blood sugar is stable, and the glycated hemoglobin is below 8%; ? signed informed consent, outpatient and inpatients who can be followed up for a long time.

Exclusion criteria

Exclusion criteria: ? blood pressure <90/60mmHg; ? patients with blood creatinine increased to 2 times in the past six months; ? unilateral or bilateral renal artery stenosis; ? other serious diabetic complications and severe macrovascular events in the past six months, such as cerebral hemorrhage, large-area cerebral infarction, acute myocardial infarction; ? patients with various infectious diseases in the past 4 weeks; ? combined with other serious diseases, such as blood system diseases, malignant tumors, etc.; ? serious psychological or mental abnormalities; ? pregnant or lactating women. Note: Any item that meets the above conditions will not be included in this study.

Design outcomes

Primary

MeasureTime frame
24-hour urine protein quantitation;

Secondary

MeasureTime frame
Urinary microalbumin creatinine ratio;fasting plasma glucose;glycosylated hemoglobin;blood lipoid;renal function;

Countries

China

Contacts

Public ContactNing Zhang
znice3927@126.com+86 010-84739030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026